Sign in

CIK 0001137883

  • Non-accelerated filer
  • Smaller reporting company

BRAINSTORM CELL THERAPEUTICS INC.

Sign in to watch
Ticker
BCLI
Exchange
OTC
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
207273918
Phone
+1 201-488-0460
Business address
1325 AVENUE OF AMERICAS, 28TH FLOOR, NEW YORK, NY, 10019
Former names
BRAINSTORM CELL THERAPEUTICS INC, GOLDEN HAND RESOURCES INC, WIZBANG TECHNOLOGIES INC
  1. 4 Derivatives Options or other derivatives
  2. 4 Grant or award EVP & Chief Business Officer acquired 5,543 shares (grant or award)
  3. 4 Grant or award COO and Chief Medical Officer acquired 35,885 shares (grant or award)
  4. 3 Insider Initial Statement of Ownership
  5. 4 Grant or award Director acquired 3,012 shares (grant or award)
  6. 3 Insider Initial Statement of Ownership
  7. 4 Derivatives Options or other derivatives
  8. 3 Insider Initial Statement of Ownership
  9. 3 Insider Initial Statement of Ownership
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Grant or award Director acquired 8,666 shares (grant or award)
  15. 4 Grant or award Director acquired 8,666 shares (grant or award)
  16. 4 Open-market sale Director sold 10,800 shares at $2.71 ($29,268)
  17. 4 Open-market sale Director sold 5,000 shares at $2.57 ($12,850)
  18. 4 Open-market sale Director sold 41,742 shares at an average $2.60 ($108,721)
  19. 4 Open-market sale Director sold 10,800 shares at an average $2.64 ($28,473)
  20. 4 Open-market sale Director sold 13,480 shares at an average $2.73 ($36,857)

Page 8 of 17 · 329 filings